Protective Effect of Ganshuang Granules (肝爽颗粒) on Liver Cirrhosis by Suppressing Regulatory T Cells in Mouse Model

Yan-min LIU; Hong-bo SHI; Yi-rong LIU; Hong-lin SHI; Feng REN; Yu CHEN; De-xi CHEN; Jin-li LOU; Zhong-ping DUAN

doi:10.1007/s11655-015-2430-9

Your Location：

Home >

Browse articles >

Protective Effect of Ganshuang Granules (肝爽颗粒) on Liver Cirrhosis by Suppressing Regulatory T Cells in Mouse Model

Original Article | Updated：2021-08-27

- Protective Effect of Ganshuang Granules (肝爽颗粒) on Liver Cirrhosis by Suppressing Regulatory T Cells in Mouse Model
- Chinese Journal of Integrative Medicine Vol. 25, Issue 1, Pages: 51-58(2019)
- Affiliations：
  
  1.Department of Liver Diseases Immunology, Beijing Youan Hospital, Capital Medical University, Beijing (100069), China
  2.Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing (100069), China
  3.Department of Toxic Hepatic Disease, Beijing Youan Hospital, Capital Medical University, Beijing (100069), China
  4.Artifical Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing (100069), China
  5.Clinical Laboratory Center, Beijing Youan Hospital, Capital Medical University, Beijing (100069), China
- Author bio：
  
  Correspondence to: Dr. DUAN Zhong-ping, Tel: 86-10-63291007, E-mail: duan2517@163.com
- Funds：
- DOI：10.1007/s11655-015-2430-9
  CLC：
- Published：01 January 2019，
  
  Published Online：05 November 2015，
  
  Accepted：10 April 2015
Scan for full text
Yan-min LIU, Hong-bo SHI, Yi-rong LIU, et al. Protective Effect of Ganshuang Granules (肝爽颗粒) on Liver Cirrhosis by Suppressing Regulatory T Cells in Mouse Model. [J]. Chinese Journal of Integrative Medicine 25(1):51-58(2019)
DOI：

Yan-min LIU, Hong-bo SHI, Yi-rong LIU, et al. Protective Effect of Ganshuang Granules (肝爽颗粒) on Liver Cirrhosis by Suppressing Regulatory T Cells in Mouse Model. [J]. Chinese Journal of Integrative Medicine 25(1):51-58(2019) DOI： 10.1007/s11655-015-2430-9.

摘要

Abstract

Objective:

To investigate the potential antifibrotic mechanisms of Chinese medicine Ganshuang Granules (肝爽颗粒

GSG) and to provide clinical therapeutic evidence of its effects.

Methods:

A cirrhotic mouse model was established by intraperitoneally injecting a mixture of CCl

(40%) and oil (60%) at 0.2 mL per 100 g of body weight twice a week for 12 weeks. After 12-week modeling

GSG was intragastric administrated to the mice for 2 weeks

and the mice were divided into low-

medium- and high-dose groups at doses of 1

2 and 4 g/(kg•day)

respectively. Liver morphology changes were observed using Masson's trichrome staining and B-ultrasound. The levels of alanine aminotransferase (ALT)

aspartate aminotransferase (AST) and hyaluronic acid (HA) in serum were detected using an automatic biochemistry analyzer. The expressions of desmin

smooth muscle actin (SMA) and Foxp3 in liver were detected by immunofluorescence. The regulatory T cell (Treg) frequency was determined through flow cytometry analysis. Collagen-Ⅰ

SMA

IL-6

tumor necrosis factor α (TNF-α)

interleukin (IL)-1β and transforming growth factor β1 (TGF-β1) expression levels were measured using quantitative polymerase chain reaction (qPCR).

Results:

Masson's staining result showed fewer pseudolobule structures and fibrous connective tissue in the GSG-treatment groups than in the spontaneous recovery group. Ultrasonography showed that GSG treatment reduced the number of punctate hyperechoic lesions in mice cirrhotic livers. The serum ALT

AST

HA levels were significantly ameliorated by GSG treatment (ALT:

=8.104

=0.000; AST:

=7.078

=0.002; and HA:

=7.621

=0.001). The expression levels of collagen-Ⅰ and SMA in the cirrhotic livers were also attenuated by GSG treatment (collagen-Ⅰ:

=3.938

=0.011; SMA:

=4.115

=0.009). Tregs

which were elevated in the fibrotic livers

were suppressed by GSG treatment (

=8.268

=0.001). The expressions of IL-6

TNF-α and IL-1β increased

and TGF-β levels decreased in the cirrhotic livers after GSG treatment (IL-6:

=5.457

=0.004; TNF-α:

=6.023

=0.002; IL-1β:

=6.658

=0.001; and TGF-β1:

=11.239

=0.000).

Conclusions:

GSG promoted the resolution/regression of cirrhosis and restored liver functions in part by suppressing Treg cell differentiation

which may be mediated by hepatic stellate cells.

关键词

Keywords

Ganshuang Granulesliver cirrhosisregulatory T cellhepatic stellate cellChinese medicine

references

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial

Related Author

No data

Related Institution

Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University

Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Disease, Beijing Ditan Hospital, Capital Medical University

National Center for Infectious Diseases

Peking University Ditan Teaching Hospital

Central of Integrated Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰